疫苗接种不良事件紧急处理中国急诊专家共识

2021-02-04 中国医师协会急诊医师分会 中国急救医学.2021.41(2):93-100.

传染病一直是人类健康最大的威胁之一,天花、脊髓灰质炎、麻疹、风疹曾给人类社会造成极大伤亡,随着疫苗的发明伤亡已经大大减少甚至基本被消灭。疫苗在人类健康史上具有里程碑意义,接种疫苗是迄今为止最有效的保护

中文标题:

疫苗接种不良事件紧急处理中国急诊专家共识

发布日期:

2021-02-04

简要介绍:

传染病一直是人类健康最大的威胁之一,天花、脊髓灰质炎、麻疹、风疹曾给人类社会造成极大伤亡,随着疫苗的发明伤亡已经大大减少甚至基本被消灭。疫苗在人类健康史上具有里程碑意义,接种疫苗是迄今为止最有效的保护全社会免受传染病危害的公共卫生措施之一。现代的疫苗相对是很安全的,但仍然存在着少许不良反应。疫苗接种的安全性和有效性同等重要,如果出现了不良事件而没有恰当处理,尤其是严重不良事件,不仅对个体产生不良影响,也会导致全社会对疫苗的不信任,从而对传染病防控造成不良后果。世界卫生组织( WHO) 认为对疫苗接种的不信任是威胁全球的十大健康问题之一。为了确保预防接种的顺利开展,对疫苗接种后急性不良事件采取恰当的紧急处理措施,是疫苗接种工作的一项重要内容。为此,中国医师协会急诊医师分会组织急诊医学及相关学科专家共同制定此共识。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=疫苗接种不良事件紧急处理中国急诊专家共识_徐胜勇.pdf)] GetToolGuiderByIdResponse(projectId=1, id=174831c002060386, title=疫苗接种不良事件紧急处理中国急诊专家共识, enTitle=, guiderFrom=中国急救医学.2021.41(2):93-100., authorId=0, author=, summary=传染病一直是人类健康最大的威胁之一,天花、脊髓灰质炎、麻疹、风疹曾给人类社会造成极大伤亡,随着疫苗的发明伤亡已经大大减少甚至基本被消灭。疫苗在人类健康史上具有里程碑意义,接种疫苗是迄今为止最有效的保护, cover=https://img.medsci.cn/2021214/1613236477589_2020535.jpg, journalId=0, articlesId=null, associationId=327, associationName=中国医师协会急诊医师分会, associationIntro=急诊科医师分会成立将推动急诊发展,为抢救患者生命,维护人民健康做出更大贡献,分会将就急诊科自身建设、行业发展、自律维权、科研合作、文化建设等问题展开工作,把分会建成为急诊科医师温馨家园!, copyright=0, guiderPublishedTime=Thu Feb 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>传染病一直是人类健康最大的威胁之一,天花、脊髓灰质炎、麻疹、风疹曾给人类社会造成极大伤亡,随着疫苗的发明伤亡已经大大减少甚至基本被消灭。疫苗在人类健康史上具有里程碑意义,接种疫苗是迄今为止最有效的保护全社会免受传染病危害的公共卫生措施之一。现代的疫苗相对是很安全的,但仍然存在着少许不良反应。疫苗接种的安全性和有效性同等重要,如果出现了不良事件而没有恰当处理,尤其是严重不良事件,不仅对个体产生不良影响,也会导致全社会对疫苗的不信任,从而对传染病防控造成不良后果。世界卫生组织( WHO) 认为对疫苗接种的不信任是威胁全球的十大健康问题之一。为了确保预防接种的顺利开展,对疫苗接种后急性不良事件采取恰当的紧急处理措施,是疫苗接种工作的一项重要内容。为此,中国医师协会急诊医师分会组织急诊医学及相关学科专家共同制定此共识。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=7819, tagName=疫苗接种)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=35, categoryName=预防与公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=7819, guiderKeyword=疫苗接种, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=23541, appHits=267, showAppHits=0, pcHits=981, showPcHits=23274, likes=3, shares=16, comments=17, approvalStatus=1, publishedTime=Sun Feb 14 01:22:16 CST 2021, publishedTimeString=2021-02-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 14 01:14:47 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:46:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=疫苗接种不良事件紧急处理中国急诊专家共识_徐胜勇.pdf)])
疫苗接种不良事件紧急处理中国急诊专家共识_徐胜勇.pdf
下载请点击:
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1013310, encodeId=c9b3101331031, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210831/368d8539d7524b259f28bc64ae066752/1f5e4c88ee424de79403b84085524ca5.jpg, createdBy=a87f1302734, createdName=dryh1967, createdTime=Tue Aug 31 22:07:03 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003987, encodeId=73b5100398e2e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d385560625, createdName=别找我麻烦, createdTime=Fri Jul 30 21:16:12 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995633, encodeId=d5e999563384, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=174e5539844, createdName=ms6000000125961612, createdTime=Sat Jul 03 09:35:07 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974410, encodeId=c1979e44105a, content=非常不错的资源, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Jun 17 15:21:11 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954288, encodeId=fe5b954288e2, content=学习好资料!!很好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cae5477453, createdName=ms7000002097940095, createdTime=Tue Apr 06 19:34:36 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-08-31 dryh1967

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1013310, encodeId=c9b3101331031, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210831/368d8539d7524b259f28bc64ae066752/1f5e4c88ee424de79403b84085524ca5.jpg, createdBy=a87f1302734, createdName=dryh1967, createdTime=Tue Aug 31 22:07:03 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003987, encodeId=73b5100398e2e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d385560625, createdName=别找我麻烦, createdTime=Fri Jul 30 21:16:12 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995633, encodeId=d5e999563384, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=174e5539844, createdName=ms6000000125961612, createdTime=Sat Jul 03 09:35:07 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974410, encodeId=c1979e44105a, content=非常不错的资源, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Jun 17 15:21:11 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954288, encodeId=fe5b954288e2, content=学习好资料!!很好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cae5477453, createdName=ms7000002097940095, createdTime=Tue Apr 06 19:34:36 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-07-30 别找我麻烦

    学习好资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1013310, encodeId=c9b3101331031, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210831/368d8539d7524b259f28bc64ae066752/1f5e4c88ee424de79403b84085524ca5.jpg, createdBy=a87f1302734, createdName=dryh1967, createdTime=Tue Aug 31 22:07:03 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003987, encodeId=73b5100398e2e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d385560625, createdName=别找我麻烦, createdTime=Fri Jul 30 21:16:12 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995633, encodeId=d5e999563384, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=174e5539844, createdName=ms6000000125961612, createdTime=Sat Jul 03 09:35:07 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974410, encodeId=c1979e44105a, content=非常不错的资源, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Jun 17 15:21:11 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954288, encodeId=fe5b954288e2, content=学习好资料!!很好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cae5477453, createdName=ms7000002097940095, createdTime=Tue Apr 06 19:34:36 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-07-03 ms6000000125961612

    学习好资料

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1013310, encodeId=c9b3101331031, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210831/368d8539d7524b259f28bc64ae066752/1f5e4c88ee424de79403b84085524ca5.jpg, createdBy=a87f1302734, createdName=dryh1967, createdTime=Tue Aug 31 22:07:03 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003987, encodeId=73b5100398e2e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d385560625, createdName=别找我麻烦, createdTime=Fri Jul 30 21:16:12 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995633, encodeId=d5e999563384, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=174e5539844, createdName=ms6000000125961612, createdTime=Sat Jul 03 09:35:07 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974410, encodeId=c1979e44105a, content=非常不错的资源, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Jun 17 15:21:11 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954288, encodeId=fe5b954288e2, content=学习好资料!!很好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cae5477453, createdName=ms7000002097940095, createdTime=Tue Apr 06 19:34:36 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-06-17 taken110

    非常不错的资源

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1013310, encodeId=c9b3101331031, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210831/368d8539d7524b259f28bc64ae066752/1f5e4c88ee424de79403b84085524ca5.jpg, createdBy=a87f1302734, createdName=dryh1967, createdTime=Tue Aug 31 22:07:03 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003987, encodeId=73b5100398e2e, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d385560625, createdName=别找我麻烦, createdTime=Fri Jul 30 21:16:12 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995633, encodeId=d5e999563384, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=174e5539844, createdName=ms6000000125961612, createdTime=Sat Jul 03 09:35:07 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974410, encodeId=c1979e44105a, content=非常不错的资源, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Thu Jun 17 15:21:11 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954288, encodeId=fe5b954288e2, content=学习好资料!!很好。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7cae5477453, createdName=ms7000002097940095, createdTime=Tue Apr 06 19:34:36 CST 2021, time=2021-04-06, status=1, ipAttribution=)]
    2021-04-06 ms7000002097940095

    学习好资料!!很好。

    0

拓展阅读

2015 ACOG委员会意见:人类乳头瘤病毒疫苗接种(No.641)

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2015-06-29

新生儿期疫苗接种及相关问题建议

中国医师协会新生儿专业委员会 · 2017-06-30

老年人流感和肺炎链球菌疫苗接种中国专家建议

中华医学会老年医学分会 · 2018-02-20

2018 ASRM委员会意见:女性不孕症患者疫苗接种建议

美国生殖医学会(ASRM,American Society for Reproductive Medicine) · 2018-10-08

2018 香港鸡蛋过敏患者疫苗接种共识

香港医学相关专家组(统称) · 2018-10-02

ECIL-7指南:未进行移植治疗的血液恶性肿瘤患者的疫苗接种

欧洲白血病感染会议(ECIL,European Conference on Infections in Leukaemia) · 2019-02-09